Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.8382
Delayed Data
As of 3:54pm ET
 -0.0051 / -0.60%
Today’s Change
0.75
Today|||52-Week Range
2.50
-36.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues2.2M2.1M2.9M4.0M
 
 
 
 
 
Cost of Goods Sold175.1K299.2K183.4K442.1K
 
 
 
 
 
Depreciation And Amortization139.5K149.8K149.3K132.2K
 
 
 
 
 
 
Operating ExpensesGross Income1.9M1.7M2.5M3.4M
 
 
 
 
 
General Expenses6.4M8.1M6.4M7.7M
 
 
 
 
 
Research And Development2.3M4.0M2.3M3.9M
 
 
 
 
 
Total Operating Expenses6.7M8.5M6.8M8.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.5M-6.4M-3.9M-4.3M
 
 
 
 
 
Extraordinary Credit0.001.7M100.0K0.00
 
 
 
Extraordinary Charge-1.3M-1.4M-4.3M-1.6M
 
 
 
 
 
Pre-Tax Equity Earnings-261.6K-262.2K-6.2K-26.8K
 
 
 
 
 
Interest Expense On Debt927.4K966.6K1.6M2.1M
 
 
 
 
 
Other Expenses32.7K26.5K-4.8K4.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.9M-7.3M-9.7M-8.1M
 
 
 
 
 
Minority Interest0.00-100.00-241.00-340.00
 
 
 
 
Preferred Dividend---46.0K0.000.00
 
 
Net Income-6.9M-7.3M-9.7M-8.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS149.9M149.8M150.1M150.2M
 
 
 
 
 
Shares To Calculate EPS Diluted149.9M149.8M150.1M150.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05-$0.05-$0.06-$0.05
 
 
 
 
 
EPS Diluted-$0.05-$0.05-$0.06-$0.05